- Overview
- Insights
About Casey
Casey Kraning, Ph.D., is a litigation associate in the Delaware office of Fish & Richardson P.C. Dr. Kraning was previously a summer associate with the firm in 2014 and 2015, where she focused primarily on patent litigation. She earned her Ph.D. in biomedical engineering and has extensive experience researching cellular and molecular medicine. Dr. Kraning works primarily with clients in the pharmaceutical industry, but also represents clients in the semiconductor and oil and gas industries. Dr. Kraning has experience in drafting discovery, working with technical experts, conducting pre-suit diligence, and working on all stages of IPRs—assisting with everything from pre-filing diligence through drafting slides for oral argument. In the pro bono sphere, Dr. Kraning has represented clients before the U.S. Citizenship and Immigration Services agency, in Delaware family court, and is currently assisting a public defender’s office in obtaining discovery in an Eighth Amendment challenge brought by inmates on death row. She continues to seek new opportunities to grow and strengthen her practice.
Publications
The Herceptin® Battle Moves into the District Court, written with Tasha Francis and Jenny Shmuel, Fish Litigation Blog, November 22, 2017.
PTAB Splits on Instituting Challenges to Herceptin® Patents, written with Jenny Shmuel, Fish Post-Grant Alerts (August 2, 2017).
Pfizer Takes Aim at Herceptin® Patent at the PTAB, written with Jenny Shmuel, Fish Post-Grant Alerts (July 12, 2017).
The Last “Cabilly” Challenge Quietly Settles, written with Tasha Francis and Jenny Shmuel, Fish Post-Grant Alerts (May 25, 2017).
Rituxan® Patents Resurface at the PTAB, co-written with Tasha Francis and Jenny Shmuel, Fish Post-Grant Alerts (March 10, 2017).
Biogen Dodges IPR Bullet on Key Tysabri® Patents, co-written with Tasha Francis and Jenny Shmuel, Fish Litigation Blog (October 20, 2016).
Kraning-Rush C, Carey S, and Reinhart-King C. Microfabricated Collagen Tracks Facilitate Single Cell Metastatic Invasion in 3D. Integrative Biology, 2013:5 606-16.
Kraning-Rush C and Reinhart-King C. Controlling Matrix Stiffness and Topography for the Study of Tumor Cell Migration. Cell Adhesion & Migration, 2012:6 274-9.
Kraning-Rush C, Carey S, Califano J, and Reinhart-King C. Methods in Cell Biology (Chapter: Quantifying Traction Stresses in Adherent Cells) Elsevier, New York, 2012:110 139-78.
Kraning-Rush C, Califano J, and Reinhart-King C. Cellular Traction Stresses Increase with Increasing Metastatic Potential. PLoS One, 2012:7(2) e32572.
Kraning-Rush C, Carey S, Califano J, Smith B, and Reinhart-King C. The Role of the Cytoskeleton in Cellular Force Generation in 2D and 3D Environments. Physical Biology, 2011:8 015009. (selected as one of Physical Biology’s “Highlights of 2011”)
Ainslie K, Kraning C, and Desai T. Microfabrication of an Asymmetric, Multi-layered Microdevice for Controlled Release of Orally Delivered Therapeutics. Lab on a Chip, 2008:8 1042-47.
Kraning C, et al. Determination of Surface Coverage and Orientation of Reduced Cytochrome c on a Silica Surface with Polarized ATR Spectroscopy. J. Phys. Chem. C, 2007:111(35) 13062-67.
J.D., University of Pennsylvania Law School (2016) Managing Editor, Penn Intellectual Property Group Online; awarded “Best Advocate” and “Best Appellee Brief” at the Western Regional of the AIPLA Giles Rich Moot Court
Ph.D., Biomedical Engineering, Cornell University (2013) Thesis: “The Role of Force Generation in Metastatic Cancer Progression”
M.S., Biomedical Engineering, Cornell University (2012)
B.S. summa cum laude, Chemistry, Butler University (2008)
- Delaware 2016
- Pennsylvania 2017
- U.S. District Court for the District of Delaware
What's trending with Casey
Filter by
-
Blog
November 22, 2017
The Herceptin® Battle Moves into the District Court
Authors: Casey M. Kraning, Jenny Shmuel, Ph.D.
-
Blog
May 25, 2017
The Last “Cabilly” Challenge Quietly Settles
Authors: Casey M. Kraning, Jenny Shmuel, Ph.D.
-
News
April 27, 2017
Fish & Richardson Announces 15 Recent Associates
-
Blog
October 20, 2016
Biogen Dodges IPR Bullet on Key Tysabri® Patents
Authors: Casey M. Kraning, Jenny Shmuel, Ph.D.